Coya Therapeutics, Inc.
Coya Therapeutics, Inc. (COYA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · COYA · as of Sep 30, 2025
Ownership Breakdown
36
Institutional Holders
▲ 3 vs Q2
$27.11M
Total Inst. Value
▲ $1.32M vs Q2
18.21M
Shares Outstanding
freeFloat 96.34%
4.76M
13F Shares Held
▲ 271,168 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
COYA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DME CAPITAL MANAGEMENT, LP pharmaceutical preparations | 1.65M | 9.84% | 9.84% | $9.38B | Nov 14, 2025 | — held |
AIGH CAPITAL MANAGEMENT LLC pharmaceutical preparations | 1.11M | 6.61% | 6.61% | $6.30B | Oct 31, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 836.4K | 5.00% | 5.00% | $4.77B | Nov 7, 2025 | ▼ 4.1K |
CM MANAGEMENT, LLC pharmaceutical preparations | 300.0K | 1.79% | 1.79% | $1.71B | Nov 13, 2025 | ▲ 100.0K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 156.8K | 93.78% | 93.78% | $894.28M | Nov 12, 2025 | ▼ 242 |
DAUNTLESS INVESTMENT GROUP, LLC pharmaceutical preparations | 153.0K | 91.49% | 91.49% | $872.22M | Nov 14, 2025 | ▲ 101.9K |
BLACKROCK, INC. pharmaceutical preparations | 70.0K | 41.83% | 41.83% | $398.76M | Nov 12, 2025 | ▲ 1.7K |
CITADEL ADVISORS LLC pharmaceutical preparations | 65.2K | 39.01% | 39.01% | $371.87M | Nov 14, 2025 | ▲ 22.1K |
STATE STREET CORP pharmaceutical preparations | 48.1K | 28.76% | 28.76% | $274.17M | Nov 14, 2025 | — held |
MARSHALL WACE, LLP pharmaceutical preparations | 41.8K | 25.01% | 25.01% | $238.40M | Nov 13, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
11
Increased
+273.1K shares7
New Positions
first time holders7
Decreased
−30.3K shares4
Sold Out
fully exitedNet shares change (top 50)
+242.8K
+273.1K / −30.3K
Net new holders
+7
7 new / 4 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
COYA insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Pavao Mark H director | Apr 9, 2026 | Award | 10,000 | $4.53 | $45.3K | 10.0K | Form 4 ↗ |
SNYDER DAVID S Chief Financial Officer | Jan 22, 2026 | Award | 140,041 | $4.73 | $662.4K | 140.0K | Form 4 ↗ |
Grossman Fred Chief Medical Officer | Jan 22, 2026 | Award | 140,041 | $4.73 | $662.4K | 140.0K | Form 4 ↗ |
Berman Howard Executive Chairman | Jan 22, 2026 | Award | 15,257 | $4.73 | $72.2K | 15.3K | Form 4 ↗ |
Swaminathan Arun Chief Executive Officer | Jan 22, 2026 | Award | 293,983 | $4.73 | $1.39M | 294.0K | Form 4 ↗ |
Villalobos Anabella director | Jan 2, 2026 | Award | 10,000 | $5.65 | $56.5K | 10.0K | Form 4 ↗ |
GOLDSTEIN DOV A MD director | Jan 2, 2026 | Award | 10,000 | $5.65 | $56.5K | 10.0K | Form 4 ↗ |
Weinand Dieter director | Jan 2, 2026 | Award | 10,000 | $5.65 | $56.5K | 10.0K | Form 4 ↗ |
ROSS WILBUR L JR director | Jan 2, 2026 | Award | 10,000 | $5.65 | $56.5K | 10.0K | Form 4 ↗ |
Lee Ann director | Jan 2, 2026 | Award | 10,000 | $5.65 | $56.5K | 10.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Coya Therapeutics, Inc. (COYA) is primarily owned by institutional investors, who hold approximately 26.1% of total shares outstanding. Company insiders own approximately 3.66%, while retail and public investors account for the remaining 70.22%.
The largest institutional shareholder of Coya Therapeutics, Inc. is DME CAPITAL MANAGEMENT, LP, holding approximately 1.65 million shares — equal to 9.84% of outstanding shares — as of September 30, 2025.
A total of 36 institutional investors currently hold COYA stock, with a combined institutional value of approximately $27,110,611 as of the most recent 13F filing period.
Frequently asked questions
COYA ownershipCoya Therapeutics, Inc. (COYA) is primarily owned by institutional investors, who hold approximately 26.1% of shares. The largest shareholder is DME CAPITAL MANAGEMENT, LP with a 9.84% stake. Company insiders hold 3.66%. Data sourced from SEC Form 13F as of September 30, 2025.